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Background:  Hereditary transthyretin-related amyloidosis (TTRA) is an autosomal dominant disease characterized by progressive 
polyneuropathy and infiltrative cardiomyopathy. High degree of suspicion is needed for diagnosis of this condition as most of the routine 
work-up for amyloidosis is negative. DNA sequence analysis and endomyocardial biopsy are essential for diagnosis.
case:  A 48 year-old male with history of severe gastroparesis was admitted for double vision and left facial weakness for 3 weeks. He 
had ophthalmoplegia, facial nerve palsy and ataxic gait secondary to polyneuropathy of unclear etiology. During the hospitalization, he 
developed 40 beat run of monomorphic non-sustained ventricular tachycardia. ECG showed low-voltage QRS complexes despite moderate 
bi-ventricular hypertrophy on echocardiogram, suspicious for infiltrative heart disease. The left ventricular ejection fraction was depressed 
at 40%. Routine amyloidosis work-up with serum and urine protein electrophoresis, immunofixation assay, serum transthyretin levels and 
abdominal fat pad biopsy were negative. At this point, the patient had unexplained gastroparesis, polyneuropathy and cardiomyopathy.
decision Making:  Though the routine work-up for amyloidosis is negative, we had strong suspicion for amyloidosis, especially the TTRA 
subtype which often presents as progressive polyneuropathy and cardiomyopathy. An endomyocardial biopsy confirmed the diagnosis of 
TTRA. DNA sequence analysis revealed a mutation in the transthyretin gene which was also inherited by the patient’s two children. A final 
diagnosis of Hereditary TTRA was made and the patient was referred for liver transplantation evaluation which is curative of this disease.
conclusion:  This case demonstrates that high degree of suspicion is required for diagnosis of cardiac amyloidosis as it is a multisystem 
disease and can present in several forms. Hereditary TTRA is a rare subtype of amyloidosis which is curative with liver transplantation if 
recognized early on. DNA sequence analysis and endomyocardial biopsy are required for definitive diagnosis. Genetic testing of family 
members and early intervention can be lifesaving.
